Calgary, Alberta — October 14, 2025 — Leads & Copy — Ocumetics Technology Corp. will hold a webinar to discuss one-month patient results for its initial Group 1 patients that received the Ocumetics Accommodating Intraocular Lens.
The webinar, scheduled for Thursday, October 15, 2025, at 6:00 PM ET, will feature Ocumetics Director and CEO, Dean Burns, providing updates on the first-in-human study and future plans. Topics include a discussion of one-month postoperative patient results, next steps to complete the study, and a live Q&A session with Dean Burns.
Ocumetics Technology Corp. is a Canadian research and product development company focused on developing advanced vision correction solutions. The company has developed an intraocular lens designed to eliminate the need for corrective lenses by allowing the eye’s natural muscle activity to shift focus from distance to near.
Reserve your spot now at www.ocumetics.com/webinar.
Dave Burwell, Director, Investor Relations, can be reached at dave.burwell@ocumetics.com or (403) 410-7907.
Source: Ocumetics Technology Corp.
